-
1
-
-
5444235920
-
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
-
Hotta K, Matsuo K, Ueoka H, et al: Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22:3852-3859, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3852-3859
-
-
Hotta, K.1
Matsuo, K.2
Ueoka, H.3
-
2
-
-
5444235033
-
Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials
-
Hotta K, Matsuo K, Ueoka H, et al: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 22:3860-3867, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3860-3867
-
-
Hotta, K.1
Matsuo, K.2
Ueoka, H.3
-
3
-
-
5444269445
-
Meta-analysis based on abstracted data: A step in the right direction, but only a first step
-
Piedbois P, Buyse M: Meta-analysis based on abstracted data: A step in the right direction, but only a first step. J Clin Oncol 22:3839-3841, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3839-3841
-
-
Piedbois, P.1
Buyse, M.2
-
4
-
-
0028201850
-
Meta-analyses need time, collaboration, and funding
-
Piedbois P, Buyse M: Meta-analyses need time, collaboration, and funding. J Clin Oncol 12:878-880, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 878-880
-
-
Piedbois, P.1
Buyse, M.2
-
5
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials: Non-small Cell Lung Cancer Collaborative Group
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials: Non-small Cell Lung Cancer Collaborative Group. BMJ 311:899-909, 1995
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
6
-
-
0027478423
-
Meta-analysis of the literature or of individual patient data: Is there a difference?
-
Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 341:418-422, 1993
-
(1993)
Lancet
, vol.341
, pp. 418-422
-
-
Stewart, L.A.1
Parmar, M.K.2
-
7
-
-
0034816161
-
Individual patient-versus literature-based meta-analysis of survival data: Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer
-
Duchateau L, Pignon JP, Bijnens L, et al: Individual patient-versus literature-based meta-analysis of survival data: Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Control Clin Trials 22:538-547, 2001
-
(2001)
Control Clin Trials
, vol.22
, pp. 538-547
-
-
Duchateau, L.1
Pignon, J.P.2
Bijnens, L.3
-
8
-
-
4444333729
-
Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer
-
abstr 7002
-
Hamada C, Ohta M, Wada H, et al: Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer. Proc Am Soc Clin Oncol 22:617, 2004 (abstr 7002)
-
(2004)
Proc Am Soc Clin Oncol
, vol.22
, pp. 617
-
-
Hamada, C.1
Ohta, M.2
Wada, H.3
-
9
-
-
0029915893
-
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer: West Japan Study Group for Lung Cancer Surgery
-
Wada H, Hitomi S, Teramatsu T: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer: West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 14:1048-1054, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 1048-1054
-
-
Wada, H.1
Hitomi, S.2
Teramatsu, T.3
-
10
-
-
0029089575
-
Heterogeneity in meta-analysis of data from epidemiologic studies: A commentary
-
Colditz GA, Burdick E, Mosteller F: Heterogeneity in meta-analysis of data from epidemiologic studies: A commentary. Am J Epidemiol 142:371-382, 1995
-
(1995)
Am J Epidemiol
, vol.142
, pp. 371-382
-
-
Colditz, G.A.1
Burdick, E.2
Mosteller, F.3
|